Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Invested Capital (2016 - 2025)

Traws Pharma (TRAW) has disclosed Invested Capital for 14 consecutive years, with -$629000.0 as the latest value for Q4 2025.

  • For Q4 2025, Invested Capital rose 98.01% year-over-year to -$629000.0; the TTM value through Dec 2025 reached -$629000.0, up 98.01%, while the annual FY2025 figure was -$629000.0, 98.01% up from the prior year.
  • Invested Capital hit -$629000.0 in Q4 2025 for Traws Pharma, down from $4.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $49.7 million in Q3 2021 and bottomed at -$105.5 million in Q2 2024.
  • Average Invested Capital over 5 years is $13.0 million, with a median of $16.7 million recorded in 2023.
  • Year-over-year, Invested Capital surged 646.88% in 2021 and then plummeted 658.37% in 2024.
  • Traws Pharma's Invested Capital stood at $46.1 million in 2021, then plummeted by 38.62% to $28.3 million in 2022, then plummeted by 62.3% to $10.7 million in 2023, then tumbled by 396.38% to -$31.6 million in 2024, then surged by 98.01% to -$629000.0 in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$629000.0, $4.5 million, and $8.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.